Gapping down
In reaction to disappointing earnings/guidance: SEAC -7.5%, EDAP -5.8%, SIGM -2.8%
Select oil/gas related names showing early weakness: RIG -1%, CHK -0.8%, OAS -0.6%, SDRL -0.6%, BP -0.5%
Other news: CNAT -8.7% (to offer shares of its common stock in an underwritten public offering), NBG -4% (cont uncertaintly in Greece), VLTC -4% (modest pullback after yday's advance), RPTP -2.8% (priced 9.5 mln shares of its common stock at $9.00 per share), SHPG -2.5% (Hayman Capital through the entity "Coalition For Affordable Drugs" filed a petition for Inter Parties Review on a patent controlled by Shire), AXTA -1.7% (priced upsized secondary offering of 40 mln shares of common stock at $28 per share), ZIOP -1.5% (disclosed that on April 1, 2015, it filed a prospectus supplement covering the resale of 11,722,163 shares of its common stock that were originally issued to The Board of Regents of the University of Texas System)
Analyst comments: INFN -3.3% (downgraded to Neutral from Buy at Goldman), GRMN -1.8% (downgraded to Neutral from Buy at Goldman), NUVA -1% (downgraded to Underperform from Neutral at BofA/Merrill), COTY -1% (downgraded to Market Perform from Outperform at BMO Capital), SPB -0.8% (downgraded to Market Perform at BMO Capital).
In reaction to disappointing earnings/guidance: SEAC -7.5%, EDAP -5.8%, SIGM -2.8%
Select oil/gas related names showing early weakness: RIG -1%, CHK -0.8%, OAS -0.6%, SDRL -0.6%, BP -0.5%
Other news: CNAT -8.7% (to offer shares of its common stock in an underwritten public offering), NBG -4% (cont uncertaintly in Greece), VLTC -4% (modest pullback after yday's advance), RPTP -2.8% (priced 9.5 mln shares of its common stock at $9.00 per share), SHPG -2.5% (Hayman Capital through the entity "Coalition For Affordable Drugs" filed a petition for Inter Parties Review on a patent controlled by Shire), AXTA -1.7% (priced upsized secondary offering of 40 mln shares of common stock at $28 per share), ZIOP -1.5% (disclosed that on April 1, 2015, it filed a prospectus supplement covering the resale of 11,722,163 shares of its common stock that were originally issued to The Board of Regents of the University of Texas System)
Analyst comments: INFN -3.3% (downgraded to Neutral from Buy at Goldman), GRMN -1.8% (downgraded to Neutral from Buy at Goldman), NUVA -1% (downgraded to Underperform from Neutral at BofA/Merrill), COTY -1% (downgraded to Market Perform from Outperform at BMO Capital), SPB -0.8% (downgraded to Market Perform at BMO Capital).